#bnt162b2 — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #bnt162b2, aggregated by home.social.
-
Immunogenicity, reactogenicity and #safety to assess #booster #vaccinations with #BNT162b2 or double-dose #mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) – final report, https://etidiohnew.blogspot.com/2026/02/immunogenicity-reactogenicity-and.html
-
Effectiveness of #BNT162b2 and #mRNA-1273 #JN1-adapted #vaccines against #COVID19-associated #hospitalisation and #death ..., https://etidiohnew.blogspot.com/2025/07/effectiveness-of-bnt162b2-and-mrna-1273.html
-
#Immunologic and Biophysical #Features of the #BNT162b2 #JN1 – and #KP2-Adapted #COVID19 #Vaccines
Source: BioRxIV, AbstractVaccines remain a vital public health tool to reduce the burden of COVID-19. COVID-19 vaccines that are more closely matched to circulating SARS-CoV-2 lineages elicit more potent and relevant immune responses that translate to improved real-world vaccine effectiveness. The rise in prevalence of the Omicron JN.1 lineage, and subsequent derivative…
-
#Immunologic and Biophysical #Features of the #BNT162b2 #JN1 – and #KP2-Adapted #COVID19 #Vaccines
Source: BioRxIV, AbstractVaccines remain a vital public health tool to reduce the burden of COVID-19. COVID-19 vaccines that are more closely matched to circulating SARS-CoV-2 lineages elicit more potent and relevant immune responses that translate to improved real-world vaccine effectiveness. The rise in prevalence of the Omicron JN.1 lineage, and subsequent derivative…
-
#Immunologic and Biophysical #Features of the #BNT162b2 #JN1 – and #KP2-Adapted #COVID19 #Vaccines
Source: BioRxIV, AbstractVaccines remain a vital public health tool to reduce the burden of COVID-19. COVID-19 vaccines that are more closely matched to circulating SARS-CoV-2 lineages elicit more potent and relevant immune responses that translate to improved real-world vaccine effectiveness. The rise in prevalence of the Omicron JN.1 lineage, and subsequent derivative…
-
#Immunologic and Biophysical #Features of the #BNT162b2 #JN1 – and #KP2-Adapted #COVID19 #Vaccines
Source: BioRxIV, AbstractVaccines remain a vital public health tool to reduce the burden of COVID-19. COVID-19 vaccines that are more closely matched to circulating SARS-CoV-2 lineages elicit more potent and relevant immune responses that translate to improved real-world vaccine effectiveness. The rise in prevalence of the Omicron JN.1 lineage, and subsequent derivative…
-
#Immunologic and Biophysical #Features of the #BNT162b2 #JN1 – and #KP2-Adapted #COVID19 #Vaccines
Source: BioRxIV, AbstractVaccines remain a vital public health tool to reduce the burden of COVID-19. COVID-19 vaccines that are more closely matched to circulating SARS-CoV-2 lineages elicit more potent and relevant immune responses that translate to improved real-world vaccine effectiveness. The rise in prevalence of the Omicron JN.1 lineage, and subsequent derivative…
-
Persistence of immune responses of a self-amplifying RNA #COVID19vaccine (ARCT-154) versus #BNT162b2 - The Lancet Infectious Diseases https://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2824%2900060-4/fulltext “a booster dose of the novel #mRNAVaccine, #ARCT154, a self-amplifying mRNA (#saRNA) vaccine based on the #SARSCoV2 D614G variant (B.1), induced superior immunogenicity than BNT162b2 (Comirnaty; Pfizer–BioNTech) in BNT162b2-primed adults 1 month after administration.”
-
[Correspondence] Immune responses following #BNT162b2 #XBB15 #vaccination in patients on #haemodialysis in #Germany https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00783-1/fulltext?rss=yes
-
#Humoral and #cellular immune responses following #BNT162b2 #XBB15 #vaccination, Lancet Infect Dis.: https://doi.org/10.1016/S1473-3099(23)00690-4
-
Jetzt könnte alles schnell gehen: Bundeskanzlerin Merkel rechnet bereits im Dezember mit der Zulassung eines Corona-Impfstoffes in Europa. Verteilt werden könnte er dann über mehr als 50 Impfzentren in NRW.
Corona-Impfstoff für NRW